Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023-07 · 21 (7) · 753-782
DOI: 10.6004/jnccn.2023.0034 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-07. Verfasst von E Gabriela Chiorean und 38 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center. Hauptthemen laut MEDLINE: Ampulla of Vater, Common Bile Duct Neoplasms, Duodenal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 204 Literaturangaben.
Abstract (Originalsprache)
Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct), while periampullary cancers may arise from locations encompassing the head of the pancreas, distal bile duct, duodenum, or ampulla of Vater. Ampullary cancers are rare gastrointestinal malignancies, and prognosis varies greatly based on factors such as patient age, TNM classification, differentiation grade, and treatment modality received. Systemic therapy is used in all stages of ampullary cancer, including neoadjuvant therapy, adjuvant therapy, and first-line or subsequent-line therapy for locally advanced, metastatic, and recurrent disease. Radiation therapy may be used in localized ampullary cancer, sometimes in combination with chemotherapy, but there is no high-level evidence to support its utility. Select tumors may be treated surgically. This article describes NCCN recommendations regarding management of ampullary adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fred Hutchinson Cancer Center.
- University of Colorado Cancer Center.
- UCSF Helen Diller Family Comprehensive Cancer Center.
- Moffitt Cancer Center.
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- Vanderbilt-Ingram Cancer Center.
Zitieren
APA
Chiorean, E. G., Chiaro, M. D., Tempero, M. A., Malafa, M. P., Benson, A. B., Cardin, D. B., Christensen, J. A., Chung, V., Czito, B., Dillhoff, M., Donahue, T. R., Dotan, E., Fountzilas, C., Glazer, E. S., Hardacre, J., Hawkins, W. G., Klute, K., Ko, A. H., Kunstman, J. W., …, & Darlow, S. D. (2023). Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(7), 753-782. https://doi.org/10.6004/jnccn.2023.0034
Vancouver
Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, et al. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;21(7):753-782. doi:10.6004/jnccn.2023.0034
BibTeX
@article{Chiorean2023,
author = {Chiorean, E Gabriela and Chiaro, Marco Del and Tempero, Margaret A and Malafa, Mokenge P and Benson, Al B and Cardin, Dana B and Christensen, Jared A and Chung, Vincent and Czito, Brian and Dillhoff, Mary and Donahue, Timothy R and Dotan, Efrat and Fountzilas, Christos and Glazer, Evan S and Hardacre, Jeffrey and Hawkins, William G and Klute, Kelsey and Ko, Andrew H and Kunstman, John W and LoConte, Noelle and Lowy, Andrew M and Masood, Ashiq and Moravek, Cassadie and Nakakura, Eric K and Narang, Amol K and Nardo, Lorenzo and Obando, Jorge and Polanco, Patricio M and Reddy, Sushanth and Reyngold, Marsha and Scaife, Courtney and Shen, Jeanne and Truty, Mark J and Vollmer, Charles and Wolff, Robert A and Wolpin, Brian M and Rn, Beth McCullough and Lubin, Senem and Darlow, Susan D},
title = {Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {7},
pages = {753--782},
doi = {10.6004/jnccn.2023.0034}
}
EUVIMED